JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 138 filers reported holding JUNO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $255,000 | -61.4% | 5,588 | -62.0% | 0.22% | -62.7% |
| Q3 2017 | $660,000 | +22.9% | 14,720 | -18.1% | 0.59% | +20.3% |
| Q2 2017 | $537,000 | +34.2% | 17,970 | -0.3% | 0.49% | +65.7% |
| Q1 2017 | $400,000 | +85.2% | 18,030 | +57.1% | 0.30% | +72.7% |
| Q4 2016 | $216,000 | +3.8% | 11,478 | +65.9% | 0.17% | +47.0% |
| Q3 2016 | $208,000 | -34.2% | 6,918 | +37.0% | 0.12% | -53.2% |
| Q2 2015 | $316,000 | – | 5,050 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,055,857,000 | 100.00% |
| Omega Fund Management, LLC | 1,329,512 | $54,098,000 | 30.46% |
| SOUND ENERGY PARTNERS, INC. | 25,800 | $1,050,000 | 2.12% |
| Graticule Asia Macro Advisors LLC | 435,205 | $17,708,000 | 2.06% |
| BB BIOTECH AG | 1,305,000 | $53,100,000 | 1.68% |
| Kazazian Asset Management, LLC | 13,376 | $544,000 | 0.69% |
| Rock Springs Capital Management LP | 197,001 | $8,016,000 | 0.65% |
| TURNER INVESTMENTS LLC | 69,680 | $2,835,000 | 0.57% |
| MIZUHO SECURITIES USA LLC | 49,600 | $2,018,000 | 0.52% |
| Private Capital Advisors, Inc. | 27,900 | $1,135,000 | 0.48% |